Lung Cancer News and Research

Latest Lung Cancer News and Research

CEBP journal emphasizes on the most up-to-date research of tobacco use

The study of tobacco has been the life-long focus of his research and now, Peter Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, has led the effort to edit a special-edition of Cancer Epidemiology, Biomarkers & Prevention (CEBP) dedicated to best research practices in tobacco science from researchers the world over.

4 Dec 2009

Cancer-free status does not lead to resumption of smoking among former smokers

Assurance of a cancer-free status did not prompt people participating in a long-term computerized tomography (CT) lung-cancer screening program to pick up their cigarettes again, researchers wrote in a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

4 Dec 2009

LCA-MA 2009 Report Card on Lung Cancer released

Today, Lung Cancer Alliance-Massachusetts (LCA-MA) issued its 3rd Annual Report Card on Lung Cancer. The 2009 Report Card is an assessment of progress being made against this lethal disease in the state of Massachusetts.

4 Dec 2009

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09

A team of scientists at the Translational Genomics Research Institute (TGen) won a $1,000 prize for best scientific paper presented at BIBM09, a premier bioinformatics and biomedicine conference.

3 Dec 2009

AACR offers a compendium of best research practices to aid the FDA in regulating tobacco

When President Barack Obama signed the Family Smoking Prevention and Control Act in June, he ushered in a new era of tobacco policy that empowers the Food and Drug Administration to regulate one of the world's most controversial and deadly consumer products.

3 Dec 2009

Children exposed to secondhand smoke face increased risk of lung cancer later in life

Children exposed to secondhand cigarette smoke have an increased risk of developing lung cancer in adulthood, even if they never smoked.

3 Dec 2009

Biomoda appeals N.M. congressional delegation to support Lung Cancer Mortality legislation

Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) today urged the New Mexico congressional delegation to support the Lung Cancer Mortality Reduction Act of 2009, which calls for a comprehensive federal program to achieve a 50% reduction in the mortality rate of lung cancer by 2016.

3 Dec 2009

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.

3 Dec 2009

People who smoke immediately after waking up face high risk of lung cancer

People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smoke, regardless of the number of cigarettes smoked.

3 Dec 2009

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

Earlier diagnosis of people with cancer could save between 5,000 and 10,000 lives each year, Professor Mike Richards, the National Cancer Director for England, has claimed.

3 Dec 2009

Researchers attribute modest improvement in lung cancer patients to novel targeted therapies

Research released in the December 2009 issue of the Journal of Thoracic Oncology sought to determine whether the survival improvement among patients with metastatic lung cancer has improved over the last two decades as reported in controlled clinical trials.

2 Dec 2009

NuGEN Technologies launches its next generation Ovation RNA-Seq System

NuGEN Technologies, Inc., a pace-setter in genomic sample preparation, enters the next generation sequencing (NGS) market today with its Ovation RNA-Seq System, a revolutionary method of sample preparation that broadens research horizons with a more comprehensive representation of the transcriptome created from samples of a few hundred picograms.

2 Dec 2009

Cancer Prevention Research Conference highlights new research on cancer

The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.

2 Dec 2009

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

1 Dec 2009

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

New figures show there was a steady decline in cancer deaths in the European Union between 1990-1994 and 2000-2004.

1 Dec 2009

Cancer patient's chances of surviving for at least a year varies depending on where they live

CANCER RESEARCH UK is calling on the government and PCTs across the country to act urgently after shocking new figures, out today (Tuesday), reveal a cancer patient's chances of surviving for at least a year varies hugely depending on where they live.

1 Dec 2009

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

Researchers from VU University Medical Center in Amsterdam have reported that RapidArc® radiotherapy from Varian Medical Systems has clinical advantages over earlier fixed-beam approaches to stereotactic treatments of lung tumors. Their findings, based on treatment of 85 medically inoperable lung cancer patients, were reported at the recent annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago and a condensed version has been published in the 'Green Journal' (Radiotherapy and Oncology) 93 (2009).

1 Dec 2009

BioMarin Pharmaceutical receives FDA orphan drug designation for 3,4-DAP

BioMarin Pharmaceutical Inc. announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received orphan drug designation in the E.U.

30 Nov 2009

HPS offers recommendations against potential risks caused by radon in indoor environment

Radon is a colorless and odorless radioactive gas that is produced by the radioactive decay of radium. Radium is a product of uranium decay and is found in trace amounts naturally in nearly all rocks, soils, and groundwater as well as building materials, plants, animals, and the human body.

30 Nov 2009

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 29 to December 3 at McCormick Place in Chicago, Siemens Healthcare will introduce its comprehensive portfolio for imaging in interventional oncology at booth #825, East Building/Lakeside Center, Hall D.

30 Nov 2009

Lung Cancer News and Research

Latest Lung Cancer News and Research

CEBP journal emphasizes on the most up-to-date research of tobacco use

Cancer-free status does not lead to resumption of smoking among former smokers

LCA-MA 2009 Report Card on Lung Cancer released

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09

AACR offers a compendium of best research practices to aid the FDA in regulating tobacco

Children exposed to secondhand smoke face increased risk of lung cancer later in life

Biomoda appeals N.M. congressional delegation to support Lung Cancer Mortality legislation

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

People who smoke immediately after waking up face high risk of lung cancer

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

Researchers attribute modest improvement in lung cancer patients to novel targeted therapies

NuGEN Technologies launches its next generation Ovation RNA-Seq System

Cancer Prevention Research Conference highlights new research on cancer

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

Cancer patient's chances of surviving for at least a year varies depending on where they live

Varian Medical Systems' RapidArc radiotherapy enables faster stereotactic treatment of lung tumors

BioMarin Pharmaceutical receives FDA orphan drug designation for 3,4-DAP

HPS offers recommendations against potential risks caused by radon in indoor environment

Siemens Healthcare to introduce high-end imaging systems for interventional oncological procedures at RSNA 2009

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Lung Cancer News and Research

Latest Lung Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in